Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip M Brown

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Gut|March 10, 2017
What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liverPhilip M Brown, Yaron Rotman
Current Pharmaceutical Design|March 12, 2015
Rheumatoid arthritis: an evolutionary force in biologicsPhilip M Brown, John D Isaacs
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2002
Lack of pharmacokinetic interactions between argatroban and warfarinPhilip M Brown, Marcie J Hursting
Clinical Medicine (London, England)|December 4, 2014
Rheumatoid arthritis: from palliation to remission in two decadesPhilip M Brown, John D Isaacs
Hepatology (Baltimore, Md.)|November 24, 2019
REPLYYanling Ma, Philip M Brown, Yaron Rotman
Calcified Tissue International|October 6, 2011
Absence of glutamine supplementation prevents differentiation of murine calvarial osteoblasts to a mineralizing phenotypePhilip M Brown, James D Hutchison, Julie C Crockett
Critical Care Medicine|April 9, 2004
Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapyMarian P LaMonte, Philip M Brown, Marcie J Hursting
The Clinical Teacher|January 10, 2012
A novel 3D stereoscopic anatomy tutorialPhilip M Brown, Neil M Hamilton, Alan R Denison
Expert Review of Cardiovascular Therapy|February 23, 2005
Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitorMarian P LaMonte, Philip M Brown, Marcie J Hursting
Nature Reviews. Rheumatology|November 5, 2016
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkersPhilip M Brown, Arthur G Pratt, John D Isaacs
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Gut|March 10, 2017
What if Prometheus had steatosis? Potential use of FGF19 to promote regeneration of the fatty liverPhilip M Brown, Yaron Rotman
Current Pharmaceutical Design|March 12, 2015
Rheumatoid arthritis: an evolutionary force in biologicsPhilip M Brown, John D Isaacs
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2002
Lack of pharmacokinetic interactions between argatroban and warfarinPhilip M Brown, Marcie J Hursting
Clinical Medicine (London, England)|December 4, 2014
Rheumatoid arthritis: from palliation to remission in two decadesPhilip M Brown, John D Isaacs
Hepatology (Baltimore, Md.)|November 24, 2019
REPLYYanling Ma, Philip M Brown, Yaron Rotman
Calcified Tissue International|October 6, 2011
Absence of glutamine supplementation prevents differentiation of murine calvarial osteoblasts to a mineralizing phenotypePhilip M Brown, James D Hutchison, Julie C Crockett
Critical Care Medicine|April 9, 2004
Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapyMarian P LaMonte, Philip M Brown, Marcie J Hursting
The Clinical Teacher|January 10, 2012
A novel 3D stereoscopic anatomy tutorialPhilip M Brown, Neil M Hamilton, Alan R Denison
Expert Review of Cardiovascular Therapy|February 23, 2005
Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitorMarian P LaMonte, Philip M Brown, Marcie J Hursting
Nature Reviews. Rheumatology|November 5, 2016
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkersPhilip M Brown, Arthur G Pratt, John D Isaacs
Pageof 5